Melatonin attenuates repeated mild traumatic brain injury-induced cognitive deficits by inhibiting astrocyte reactivation

• DOI: 10.1016/j.bbrc.2021.09.025
• Publication Date: 2021-09-17T07:41:59Z
• Authors: Rong Cao; Lin Li; Wen Zhang; Jun Lu; Yu Wang; Qian Chen; Wentong Zhang; Mingming Chen; Liang Sheng; Keshu Cai; Guangxu Xu
• Keywords: Male; Mice; 03 medical and health sciences; Neuroprotective Agents; 0302 clinical medicine; Astrocytes; Brain Injuries, Traumatic; Animals; Cognitive Dysfunction; Melatonin

Melatonin has been well documented for its neuroprotective role through inhibiting oxidative stress against traumatic brain injury (TBI). However, the specific role of melatonin and the exact effects on cell responses (neurons, astrocytes, and microglia) in different brain regions are unclear. Here, we subjected mice to closed head injury, to establish a repeated mild TBI model and detect neuronal activity and glial responses in cognition-related brain regions after melatonin administration. Melatonin only showed cognitive enhancement if administered during early pathological stages, but not in late (chronic) stages. Additionally, we observed a significant increase in neuronal activity and inhibition of astrocyte reactivation in medial prefrontal cortex and hippocampus, but not in other cognitive deficit related brain regions. Furthermore, by activating astrocytes in these brain regions, we found neuronal activity upregulation and cognitive improvement following melatonin treatment. Therefore, we concluded that melatonin administration during the early stages of TBI is necessary to inhibit astrocyte reactivation and to promote cognitive function. Our results provide evidence for use of melatonin for cognitive improvement after TBIs.